PORTFOLIO

  • Ex vivo
  • In vivo
Delivery Pipeline POC Pre-IND IIT Phase Ⅰ Phase Ⅱ
Ex vivo β-thalassemia
Sickle cell disease
In vivo Hypertriglyceridemia
Obesity/Diabetes
Oncology
Hypertension
Neurogenerative Disease
CorrectSequence Therapeutics Co., Ltd. © (2021-2025)沪ICP备2020032248号
Powered by MetInfo 7.7 ©2008-2025  mituo.cn
HOME
ABOUT
NEWS
CONTACT